vanish testes syndrome

68
Dr.YASSIN M ALSALEH

Upload: yassin-alsaleh

Post on 07-May-2015

265 views

Category:

Health & Medicine


2 download

DESCRIPTION

Vanish testes syndrome testicular regression syndrome

TRANSCRIPT

Page 1: Vanish testes syndrome

Dr.YASSIN M ALSALEH

Page 2: Vanish testes syndrome

Page 2

2 years 6 months old boy.

Product of FT, NSVD.

Upon delivery, patient found to have empty scrotum.

On exam:

SPL 4 cm .

Testicles not palpable bilaterally.2

Case scenario

Page 3: Vanish testes syndrome

Page 3

US done in ALHOUTA , they cauld not find testicles.

So patient refered to pediatric surgery in KFMC .

patient accepted for Laparoscopic exploration and orchedopexy.

3

Case scenario

Page 4: Vanish testes syndrome

Page 4

Karyotyping: 46XY.

FSH: 163.5 IU/L high.

LH : 6.1 IU/L.

Testerone level pre and post HCG stimulation : less than 0.08 nmol/L.

US: testicle could not be visualized.4

Case scenario

Page 5: Vanish testes syndrome

Page 5 5

Page 6: Vanish testes syndrome

Page 6 6

Page 7: Vanish testes syndrome

Page 7

Intra-abdominal torsion and vanishing left testicle.

Extra-abdominal torsion and vanishing right testicle.

Finding:

very thin rudimentary vas defers.

Fibrotic vanishing testicle.

7

Case scenario

Page 8: Vanish testes syndrome

Page 8 8

Page 9: Vanish testes syndrome

Page 9 9

synonyms

Page 10: Vanish testes syndrome

Page 10

a congenital condition in which no normal testicular tissue can be identified following exploration for a clinically impalpable testis.

condition which is considered to be due to the subsequent atrophy and disappearance in fetal life of an initially normal testis.

10

introduction

Page 11: Vanish testes syndrome

Page 11

The term vanishing testis syndrome was coined for the phenotype of bilateral anorchia in an otherwise normally developed male infant.

Bilateral anorchia with normal differentiated but small phallus (micropenis) is also a recognized variant of the syndrome.

Any ambiguity of the external genitalia suggests a variant of the syndrome related to some form of XY gonadal dysgenesis.

11

introduction

Page 12: Vanish testes syndrome

Page 12

It affects one in 20,000 male births

TRS or vanishing testis syndrome affect 5% of boys with cryptorchidism.

Vanishing testis is more common than testicular agenesis .

12

prevalence

Page 13: Vanish testes syndrome

Page 13

TRS is thought to be the result of late antenatal or perinatal vascular thrombosis, torsion, or endocrinopathy.

Recent studies strongly support a vascular accident and antenatal torsion theory rather than an endocrinopathy.

13

pathophysiology

Page 14: Vanish testes syndrome

Page 14

The incompletely descended testis is thought to be more prone to torsion during the fetal and perinatal period.

This hypothesis is supported by the presence of hemosiderin-laden macrophages in surgically removed specimens ,consistent with the venous congestion and hemorrhagic infarction secondary to torsion of a structure.

14

pathophysiology

Page 15: Vanish testes syndrome

Page 15

the extent of virilization depends on the developmental stage at which testicular function is lost.

Deficient androgen secretion before 8 weeks’ gestation leads to a female internal and external phenotype that includes differentiated müllerian structures.

15

pathophysiology

Page 16: Vanish testes syndrome

Page 16

If the loss of function occurs during the critical period for male differentiation from 8 to 10 weeks’ gestation, the genitalia are ambiguous,with variable development of the wolffian and müllerian ducts.

If the vascular insult and testicular loss occur after 12 to 14 weeks gestational age, although the internal and external genitalia are male in appearance virilization is incomplete.

If the vascular insult occur after 14 to 16 weeks Usually The external genitalia are normal.

16

pathophysiology

Page 17: Vanish testes syndrome

Page 17

anatomically it is characterized by a rudimentary spermatic cord with a small mass of firm, fibrotic tissue at one end, as well as elements of the vas deferens, spermatic artery and venous plexuses.

17

Anatomy

Page 18: Vanish testes syndrome

Page 18

The most characteristic histological findings are presence of a fibrovascular nodule with associated hemosiderin-laden macrophages and dystrophic calcification.

Residual testicular tubules are found in less than 10% of cases.

Presence of seminiferous tubules and viable germ cells in testicular remnant tissue has been reported in some series.

18

histology

Page 19: Vanish testes syndrome

Page 19 19

Anatomy and histology

Page 20: Vanish testes syndrome

Page 20 20

Anatomy and histology

Page 21: Vanish testes syndrome

Page 21

In the vast majority of cases, TRS appears to be a sporadic occurrence.

Testicular regression has been observed in association with genetic abnormality such as microdeletion of the Y chromosome.

21

genetic

Page 22: Vanish testes syndrome

Page 22

Recently, a novel heterozygous missense mutation in NR5A1 encoding steroidogenic factor (SF1) gene was found in one boy with a micropenis and TRS.

The families of some patients with anorchia may include other individuals with pure or partial 46,XY gonadal dysgenesis.

22

genetic

Page 23: Vanish testes syndrome

Page 23

This disorder may be unilateral or, less commonly, bilateral, with partial or complete absence of testicular tissue and, in the majority of cases, with normal external genitalia.

Testes not detected by routine imaging studies may become palpable on careful physical examination.

23

Clinical Presentations

Page 24: Vanish testes syndrome

Page 24

TRS patients usually exhibit a male phenotype.

the phenotypic spectrum may vary from normal male with unilateral nonpalpable testis through phenotypic male with micropenis,to phenotypic female

24

Clinical Presentations

Page 25: Vanish testes syndrome

Page 25

Diagnosis

criteria are:

1) no testis palpated during an examination under anesthesia.

2) visualizing blind-ending spermatic vessels within the retroperitoneum or visualizing spermatic vessels and vas deferens exiting a closed internal inguinal ring.

25

Diagnosis

Page 26: Vanish testes syndrome

Page 26

XY karyotype.

low  testesterone levels (typical female levels).

elevated follicle stimulation hormone  .

Normal or elevated luteinizing hormone  level.

low anti-Mullerian hormone  levels.

Low inhibin B level.

26

Lab

Page 27: Vanish testes syndrome

Page 27

The basal plasma FSH concentration is increased in boys with anorchia, but it may be normal and uninformative in patients aged between 2 years to pubertal age.

High gonadotropin level and unmesurable AMH and inhibin B indicate anorchia.

Also lack of testesterone respone to HCG stimulation also consistent with anorchia.

27

Lab

Page 28: Vanish testes syndrome

Page 28

Random inhibin B and AMH may be more helpful than HCG stimulation.

unmeasurable AMH concentration was 92.3% predictive of anorchia, while a low testosterone response to hCG was only 57.1% predictive.

28

Lab

Page 29: Vanish testes syndrome

Page 29

 Imaging study are generally not informative.

Ultrasound  or magnetic resonance imaging  showing absent gonadal tissue.

Diagnostic laparoscopy has now become the preferred modality in the majority of centers. It has an accuracy of 88-100% in determining the presence, position, size and structure of the testis in various serie.

29

Imaging and laparoscope

Page 30: Vanish testes syndrome

Page 30 30

Management

Page 31: Vanish testes syndrome

Page 31 31

Medical Managementtestosterone supplementation to artificially initiate puberty.

Anorchic individuals who have a female identity may be administered estrogen

Page 32: Vanish testes syndrome

Page 32

Testosterone

Testoserone enathate, cypionate and propionate. IM

Initiate after age 12 years of age at 50 mg every 4 weeks. Increase with 50 mg every 6 to 12 months. After reaching 100-150 mg monthly ,decrease interval to every 2 weeks. adult dose 200 mg every 2 weeks

Not for use in boys with bone age <10 years.Erythrocytosis, weight gain, prostate hyperplasia. Premature epiphyseal closure .Local side effects (pain, erythema)

Testosterone undecanoate.IM

Adult dose 1000 mg every 10-14 weeks.

Testosterone gel Can be started when 50% adult dose with intramuscular testosterone achieved.

Local irritation. Avoid contact with other

32

Medical Management

Page 33: Vanish testes syndrome

Page 33

Other side effects include acne, gynecomastia.

Beneficial effects include :

decline in total plasma cholesterol and LDL concentrations, increased lean body mass, and decreased risk of osteoporosis .

33

Medical Management

Page 34: Vanish testes syndrome

Page 34 34

Medical Management

Page 35: Vanish testes syndrome

Page 35 35

Medical Management

Page 36: Vanish testes syndrome

Page 36

There is controversy regarding the optimal management of the testicular remnant in cases of TRS.

Some recommend surgical exploration, either laparoscopically or via inguinal/scrotal approach,

whereas others believe that these procedures are unnecessary

36

Surgical Management

Page 37: Vanish testes syndrome

Page 37

TRS theoretically carries a potential for malignant degeneration in the long term and therefore removal of any remnant is a common practice to eliminate this risk.

However, no case series has reported germinal dysplasia or intratubular germ cell neoplasia in any of the specimens taken from these patients.

37

Risk of Malignancy

Page 38: Vanish testes syndrome

Page 38

Most centers would currently still undertake surgical exploration to remove testicular remnants, even though there is usually no evidence of malignancy found.

Such a procedure could be deferred until the time of insertion of testicular prostheses.

38

Surgical Management

Page 39: Vanish testes syndrome

Page 39

testicular prosthetic implantation.

39

Surgical Management

Page 40: Vanish testes syndrome

Page 40 40

Surgical Management

Page 41: Vanish testes syndrome

Page 41

The histological evaluation of inguinal testicular remnants suggests that these testes became ischemic and atrophied during descent in utero or shortly after birth.

The optimal management of the testicular remnants is controversial.

authors recommend routine excision of remnants, whereas others believe that this is superfluous.

A review of the current literature has not identified any report of testicular germ cell tumors which appear to arise from TRS. 41

Conclusion

Page 42: Vanish testes syndrome

Page 42

Anorchia is rare. Undetectable plasma concentrations of AMH and inhibin B and an elevated plasma FSH, together with 46,XY complement, are sufficient for its diagnosis. The hCG test is not necessary.

Treatment with low doses of testosterone at pubertal age leads to a normal adult height.

42

Conclusion

Page 43: Vanish testes syndrome

Page 43 43

1- Ozgur Pirgon1, Bumin Nuri Dundar, Vanishing Testes: A Literature Review. J Clin Res Pediatr En docrinol. 2012;4(3):116-120.

2-Storm D, Redden T. Histologic evaluation of the testicular remnant associated with the vanishing testes syndrome: is surgical management necessary?. Urology . 2007 Dec;70(6):1204-6.

references

Page 44: Vanish testes syndrome

Page 44

3- Grady RW,Mitchell ME. Laparoscopic and histologic evaluation of the inguinal vanishing testis.Urology. 1998 Nov;52(5):866-9.

4- Emir H,Ayik B. Histological evaluation of the testicular nubbins in patients with nonpalpable testis: assessment of etiology and surgical approach. pediatric surg Int .2007 Jan;23(1):41-4. Epub 2006 Oct 10.

44

references

Page 45: Vanish testes syndrome

Page 45

5-Law H,Mushtaq I. Histopathological features of testicular regression syndrome: relation to patient age and implications for management. Fetal pediatr pathol. 2006 Mar-Apr;25(2):119-29.

6- Tariq O. Abbas, Noora Al-Shahwani .Role of Ultrasonography in the Preoperative Assessment of Impalpable Testes: A Single Center Experience. ISRN Urology.Volume 2012, Article ID 560216, 3 pages

45

references

Page 46: Vanish testes syndrome

Page 46

7-Raja Brauner .Clinical, Biological and Genetic Analysis of Anorchia in 26 Boys. PLoS ONE 6(8): e23292.

8- spires SE. Testicular regression syndrome: a clinical and pathologic study of 11 cases. Arch Pathol Lab Med . 2000 May;124(5):694-8

9- Pascal Philibert, Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod. 2007 December ; 22(12): 3255–3261. 46

references

Page 47: Vanish testes syndrome

Page 47

10- Kubini K.Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J clinical endocrinol Metabolisim. 2000 Jan;85(1):134-8.

11- Zenaty D, 2006 Nov;149(5):687-91. Bilateral anorchia in infancy: occurence of micropenis and the effect of testosterone treatment. J Pediatric.

47

references

Page 48: Vanish testes syndrome

Page 48 48

references

Page 49: Vanish testes syndrome

Page 49 49

references

Page 50: Vanish testes syndrome

Page 50 50

references

Page 51: Vanish testes syndrome

Page 51 51

references

Page 52: Vanish testes syndrome

Page 52 52

references

Page 53: Vanish testes syndrome

Page 53 53

references

Page 54: Vanish testes syndrome

Page 54 54

Page 55: Vanish testes syndrome

Page 55 55

references

Page 56: Vanish testes syndrome

Page 56 56

references

Page 57: Vanish testes syndrome

Page 57 57

references

Page 58: Vanish testes syndrome

Page 58 58

references

Page 59: Vanish testes syndrome

Page 59 59

references

Page 60: Vanish testes syndrome

Page 60 60

references

Page 61: Vanish testes syndrome

Page 61 61

references

Page 62: Vanish testes syndrome

Page 62 62

references

Page 63: Vanish testes syndrome

Page 63 63

references

Page 64: Vanish testes syndrome

Page 64 64

references

Page 65: Vanish testes syndrome

Page 65 65

references

Page 66: Vanish testes syndrome

Page 66 66

references

Page 67: Vanish testes syndrome

Page 67 67

references

Page 68: Vanish testes syndrome

Page 68 68